D. Iacuzio

Comparison of the safety, vaccine virus shedding, and immunogenicity of influenza virus vaccine, trivalent, types A and B, live cold-adapted, administered to human immunodeficiency virus (HIV)-infected and non-HIV-infected adults.

Lihan K. Yan, J. Lambert, R. Belshe, 2000, The Journal of infectious diseases.

Efficacy of vaccination with live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine against a variant (A/Sydney) not contained in the vaccine.

Lihan K. Yan, F. Hayden, J. Wittes, 2000, The Journal of pediatrics.

The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenzavirus vaccine in children.

F. Hayden, D. Bernstein, W. Gruber, 1998, The New England journal of medicine.

Evaluation of trivalent, live, cold-adapted (CAIV-T) and inactivated (TIV) influenza vaccines in prevention of virus infection and illness following challenge of adults with wild-type influenza A (H1N1), A (H3N2), and B viruses.

R. Betts, J. Wittes, F. Newman, 1999, Vaccine.

Cost-effectiveness analysis of an intranasal influenza vaccine for the prevention of influenza in healthy children.

Lihan K. Yan, B R Luce, B. Luce, 2001, Pediatrics.